• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

剪接因子 SRSF5 的乙酰化和泛素化相互排斥,控制肿瘤生长。

Mutually exclusive acetylation and ubiquitylation of the splicing factor SRSF5 control tumor growth.

机构信息

State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center of Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, 100850, China.

Department of Genomics and Proteomics, Beijing Institute of Radiation Medicine, Beijing, 100850, China.

出版信息

Nat Commun. 2018 Jun 25;9(1):2464. doi: 10.1038/s41467-018-04815-3.

DOI:10.1038/s41467-018-04815-3
PMID:29942010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6018636/
Abstract

Most tumor cells take up more glucose than normal cells. Splicing dysregulation is one of the molecular hallmarks of cancer. However, the role of splicing factor in glucose metabolism and tumor development remains poorly defined. Here, we show that upon glucose intake, the splicing factor SRSF5 is specifically induced through Tip60-mediated acetylation on K125, which antagonizes Smurf1-mediated ubiquitylation. SRSF5 promotes the alternative splicing of CCAR1 to produce CCAR1S proteins, which promote tumor growth by enhancing glucose consumption and acetyl-CoA production. Conversely, upon glucose starvation, SRSF5 is deacetylated by HDAC1, and ubiquitylated by Smurf1 on the same lysine, resulting in proteasomal degradation of SRSF5. The CCAR1L proteins accumulate to promote apoptosis. Importantly, SRSF5 is hyperacetylated and upregulated in human lung cancers, which correlates with increased CCAR1S expression and tumor progression. Thus, SRSF5 responds to high glucose to promote cancer development, and SRSF5-CCAR1 axis may be valuable targets for cancer therapeutics.

摘要

大多数肿瘤细胞比正常细胞吸收更多的葡萄糖。剪接失调是癌症的分子标志之一。然而,剪接因子在葡萄糖代谢和肿瘤发展中的作用仍未得到明确界定。在这里,我们表明,在摄入葡萄糖后,剪接因子 SRSF5 通过 Tip60 介导的 K125 乙酰化被特异性诱导,这拮抗了 Smurf1 介导的泛素化。SRSF5 促进 CCAR1 的选择性剪接产生 CCAR1S 蛋白,通过增强葡萄糖消耗和乙酰辅酶 A 生成促进肿瘤生长。相反,在葡萄糖饥饿时,SRSF5 被 HDAC1 去乙酰化,在同一赖氨酸上被 Smurf1 泛素化,导致 SRSF5 的蛋白酶体降解。CCAR1L 蛋白积累以促进细胞凋亡。重要的是,SRSF5 在人类肺癌中高度乙酰化和上调,这与 CCAR1S 表达增加和肿瘤进展相关。因此,SRSF5 响应高葡萄糖以促进癌症发展,SRSF5-CCAR1 轴可能是癌症治疗的有价值靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/2012a96d08e3/41467_2018_4815_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/829996c65543/41467_2018_4815_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/9d8055ec01f0/41467_2018_4815_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/06f45ebcfbce/41467_2018_4815_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/9c23b2c7d63f/41467_2018_4815_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/445099323a5f/41467_2018_4815_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/138f916efc9e/41467_2018_4815_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/a2b2f689ce45/41467_2018_4815_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/0bc279c1c990/41467_2018_4815_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/2fe014b40cba/41467_2018_4815_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/2012a96d08e3/41467_2018_4815_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/829996c65543/41467_2018_4815_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/9d8055ec01f0/41467_2018_4815_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/06f45ebcfbce/41467_2018_4815_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/9c23b2c7d63f/41467_2018_4815_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/445099323a5f/41467_2018_4815_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/138f916efc9e/41467_2018_4815_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/a2b2f689ce45/41467_2018_4815_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/0bc279c1c990/41467_2018_4815_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/2fe014b40cba/41467_2018_4815_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0eb/6018636/2012a96d08e3/41467_2018_4815_Fig10_HTML.jpg

相似文献

1
Mutually exclusive acetylation and ubiquitylation of the splicing factor SRSF5 control tumor growth.剪接因子 SRSF5 的乙酰化和泛素化相互排斥,控制肿瘤生长。
Nat Commun. 2018 Jun 25;9(1):2464. doi: 10.1038/s41467-018-04815-3.
2
SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.SRSF5 作为一种新型致癌剪接因子,可被口腔鳞状细胞癌中的致癌基因 SRSF3 上调。
Biochim Biophys Acta Mol Cell Res. 2018 Sep;1865(9):1161-1172. doi: 10.1016/j.bbamcr.2018.05.017. Epub 2018 May 30.
3
Antitumor activity of SR splicing-factor 5 knockdown by downregulating pyruvate kinase M2 in non-small cell lung cancer cells.下调丙酮酸激酶 M2 抑制剪接因子 SR 在非小细胞肺癌细胞中的抗肿瘤活性。
J Cell Biochem. 2019 Oct;120(10):17303-17311. doi: 10.1002/jcb.28992. Epub 2019 May 20.
4
CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.CLK1/SRSF5 通路诱导 METTL14 和 Cyclin L2 的异常外显子跳跃,促进胰腺癌的生长和转移。
J Hematol Oncol. 2021 Apr 13;14(1):60. doi: 10.1186/s13045-021-01072-8.
5
SRSF5: a novel marker for small-cell lung cancer and pleural metastatic cancer.SRSF5:一种用于小细胞肺癌和胸膜转移性癌的新型标志物。
Lung Cancer. 2016 Sep;99:57-65. doi: 10.1016/j.lungcan.2016.05.018. Epub 2016 May 26.
6
TRPV4-dependent induction of a novel mammalian cold-inducible protein SRSF5 as well as CIRP and RBM3.TRPV4 依赖性诱导新型哺乳动物冷诱导蛋白 SRSF5 以及 CIRP 和 RBM3。
Sci Rep. 2017 May 23;7(1):2295. doi: 10.1038/s41598-017-02473-x.
7
Acetylation of TIP60 at K104 is essential for metabolic stress-induced apoptosis in cells of hepatocellular cancer.乙酰化 TIP60 在 K104 对肝癌细胞代谢应激诱导的细胞凋亡是必需的。
Exp Cell Res. 2018 Jan 15;362(2):279-286. doi: 10.1016/j.yexcr.2017.11.028. Epub 2017 Nov 22.
8
Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer.源自厚朴的新型组蛋白去乙酰化酶抑制剂可显著增强TRAIL诱导的非小细胞肺癌细胞凋亡。
Pharmacol Res. 2016 Sep;111:113-125. doi: 10.1016/j.phrs.2016.05.028. Epub 2016 Jun 3.
9
Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation.致癌剪接因子 SRSF3 通过调节 ILF3 的可变剪接促进癌细胞增殖和转化。
RNA. 2019 May;25(5):630-644. doi: 10.1261/rna.068619.118. Epub 2019 Feb 22.
10
Smurf1 controls S phase progression and tumorigenesis through Wee1 degradation.Smurf1通过降解Wee1来控制S期进程和肿瘤发生。
FEBS Lett. 2017 Apr;591(8):1150-1158. doi: 10.1002/1873-3468.12624. Epub 2017 Apr 3.

引用本文的文献

1
Transcriptomic analysis reveals lung cancer and subtype-specific alternative splicing biomarkers regulated by RNA-binding proteins.转录组分析揭示了由RNA结合蛋白调控的肺癌及亚型特异性可变剪接生物标志物。
Mol Ther Nucleic Acids. 2025 Aug 12;36(3):102681. doi: 10.1016/j.omtn.2025.102681. eCollection 2025 Sep 9.
2
MRPL12 K163 acetylation inhibits ccRCC via driving mitochondrial metabolic reprogramming.MRPL12 K163位点的乙酰化通过驱动线粒体代谢重编程抑制肾透明细胞癌。
Cell Death Dis. 2025 Aug 26;16(1):646. doi: 10.1038/s41419-025-07896-3.
3
SRSF3 undergoes phase separation in lung cancer and is associated with immunity and ferroptosis.

本文引用的文献

1
Smurf1 Inhibits Osteoblast Differentiation, Bone Formation, and Glucose Homeostasis through Serine 148.Smurf1通过丝氨酸148抑制成骨细胞分化、骨形成和葡萄糖稳态。
Cell Rep. 2016 Apr 5;15(1):27-35. doi: 10.1016/j.celrep.2016.03.003. Epub 2016 Mar 24.
2
RNA mis-splicing in disease.疾病中的RNA错配剪接
Nat Rev Genet. 2016 Jan;17(1):19-32. doi: 10.1038/nrg.2015.3. Epub 2015 Nov 23.
3
Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis.去泛素化酶 OTUD3 调控 PTEN 稳定性并抑制肿瘤发生。
SRSF3在肺癌中发生相分离,并与免疫和铁死亡相关。
Sci Rep. 2025 Aug 8;15(1):29015. doi: 10.1038/s41598-025-12842-6.
4
Acetylation: a new target for protein degradation in cancer.乙酰化:癌症中蛋白质降解的新靶点。
Trends Cancer. 2025 Apr;11(4):403-420. doi: 10.1016/j.trecan.2025.01.013. Epub 2025 Mar 6.
5
A Effector Targets Splicing Factor to Reprogram Alternative Splicing and Regulate Plant Immunity.A效应因子靶向剪接因子以重编程可变剪接并调节植物免疫。
Plants (Basel). 2025 Feb 10;14(4):534. doi: 10.3390/plants14040534.
6
Comprehensive analysis of splicing factor SRs-related gene characteristics: predicting osteosarcoma prognosis and immune regulation status.剪接因子SRs相关基因特征的综合分析:预测骨肉瘤预后及免疫调节状态
Front Oncol. 2024 Sep 2;14:1456986. doi: 10.3389/fonc.2024.1456986. eCollection 2024.
7
Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma.靶向 SRSF10 可能抑制 M2 巨噬细胞极化,并增强肝癌的抗 PD-1 治疗效果。
Cancer Commun (Lond). 2024 Nov;44(11):1231-1260. doi: 10.1002/cac2.12607. Epub 2024 Sep 2.
8
Substrate and Functional Diversity of Protein Lysine Post-translational Modifications.蛋白质赖氨酸翻译后修饰的底物和功能多样性。
Genomics Proteomics Bioinformatics. 2024 May 9;22(1). doi: 10.1093/gpbjnl/qzae019.
9
LINC01852 inhibits the tumorigenesis and chemoresistance in colorectal cancer by suppressing SRSF5-mediated alternative splicing of PKM.LINC01852 通过抑制 SRSF5 介导的 PKM 可变剪接抑制结直肠癌的肿瘤发生和化疗耐药性。
Mol Cancer. 2024 Jan 24;23(1):23. doi: 10.1186/s12943-024-01939-7.
10
hGRAD: A versatile "one-fits-all" system to acutely deplete RNA binding proteins from condensates.hGRAD:一种通用的“一刀切”系统,可从液滴中急性耗尽 RNA 结合蛋白。
J Cell Biol. 2024 Feb 5;223(2). doi: 10.1083/jcb.202304030. Epub 2023 Dec 18.
Nat Cell Biol. 2015 Sep;17(9):1169-81. doi: 10.1038/ncb3218. Epub 2015 Aug 17.
4
PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumour inhibition.通过抑制 HDAC6 乙酰化激活 PTEN 有助于肿瘤抑制。
Oncogene. 2016 May 5;35(18):2333-44. doi: 10.1038/onc.2015.293. Epub 2015 Aug 17.
5
The core spliceosome as target and effector of non-canonical ATM signalling.作为非经典 ATM 信号传导的靶点和效应器的核心剪接体
Nature. 2015 Jul 2;523(7558):53-8. doi: 10.1038/nature14512. Epub 2015 Jun 24.
6
Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation.葡萄糖摄取与Runx2协同作用以调控成骨细胞分化和骨形成。
Cell. 2015 Jun 18;161(7):1576-1591. doi: 10.1016/j.cell.2015.05.029.
7
Acetyl-CoA and the regulation of metabolism: mechanisms and consequences.乙酰辅酶A与代谢调节:机制与后果
Curr Opin Cell Biol. 2015 Apr;33:125-31. doi: 10.1016/j.ceb.2015.02.003. Epub 2015 Feb 20.
8
BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells.BCLAF1 和其剪接调控因子 SRSF10 调节结肠癌细胞的致瘤潜能。
Nat Commun. 2014 Aug 5;5:4581. doi: 10.1038/ncomms5581.
9
SRSF10 regulates alternative splicing and is required for adipocyte differentiation.SRSF10调节可变剪接,是脂肪细胞分化所必需的。
Mol Cell Biol. 2014 Jun;34(12):2198-207. doi: 10.1128/MCB.01674-13. Epub 2014 Apr 7.
10
Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma.Lkb1基因缺陷小鼠的肺腺癌向鳞状细胞癌的转分化
Nat Commun. 2014;5:3261. doi: 10.1038/ncomms4261.